Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001729214-24-000001
Filing Date
2024-10-31
Accepted
2024-10-31 10:28:13
Documents
1
Effectiveness Date
2024-10-31
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13428
  Complete submission text file 0001729214-24-000001.txt   14595
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-528293 | Film No.: 241412893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)